Comparison of 30 Units of TI (Technosphere® Insulin) Prepared With Insulin From Two Different Suppliers
- Conditions
- Interventions
- First Posted Date
- 2013-11-13
- Last Posted Date
- 2014-10-02
- Lead Sponsor
- Mannkind Corporation
- Target Recruit Count
- 38
- Registration Number
- NCT01982604
Compare the Same Dosage of Insulin Using a Combination of Cartridges, 30 Units as 2 Cartridges vs. 1 Cartridge
- Conditions
- Interventions
- First Posted Date
- 2013-07-18
- Last Posted Date
- 2014-12-12
- Lead Sponsor
- Mannkind Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT01902121
Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder
- Conditions
- First Posted Date
- 2013-02-26
- Last Posted Date
- 2016-01-20
- Lead Sponsor
- Mannkind Corporation
- Registration Number
- NCT01798914
- Locations
- 🇺🇸
Endocrinology Associates, Montgomery, Alabama, United States
🇺🇸Diabetes and Endocrine Consultants P.C., Montgomery, Alabama, United States
🇺🇸Dr. Rife and Associates Family Medicine, Orland Park, Illinois, United States
Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 Diabetes
- Conditions
- Interventions
- First Posted Date
- 2012-03-06
- Last Posted Date
- 2013-01-25
- Lead Sponsor
- Mannkind Corporation
- Target Recruit Count
- 17
- Registration Number
- NCT01544881
- Locations
- 🇺🇸
Profil Institute for Clinical Research, Chula Vista, California, United States
Healthy Normal Volunteers Looking at Exposure and Effects of Multiple Doses of Technosphere® Insulin (TI) Using the Gen2C Inhaler
- Conditions
- Interventions
- First Posted Date
- 2011-12-13
- Last Posted Date
- 2012-09-07
- Lead Sponsor
- Mannkind Corporation
- Target Recruit Count
- 35
- Registration Number
- NCT01490762
- Locations
- 🇺🇸
Profil Institute for Clinical Research, Chula Vista, California, United States
Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus
- Conditions
- Interventions
- First Posted Date
- 2011-10-13
- Last Posted Date
- 2014-10-17
- Lead Sponsor
- Mannkind Corporation
- Target Recruit Count
- 353
- Registration Number
- NCT01451398
Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period
- First Posted Date
- 2011-10-04
- Last Posted Date
- 2014-10-22
- Lead Sponsor
- Mannkind Corporation
- Target Recruit Count
- 518
- Registration Number
- NCT01445951
Pharmacokinetic Study in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2011-06-03
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- Mannkind Corporation
- Target Recruit Count
- 50
- Registration Number
- NCT01365117
- Locations
- 🇺🇸
Celerion, Neptune, New Jersey, United States
Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166
- First Posted Date
- 2010-09-15
- Last Posted Date
- 2012-12-06
- Lead Sponsor
- Mannkind Corporation
- Target Recruit Count
- 3
- Registration Number
- NCT01201928
- Locations
- 🇺🇸
Billings Clinic Research Center, Billings, Montana, United States
🇺🇸SAM Clinical Research Center, San Antonio, Texas, United States
🇺🇸Valley Research, Fresno, California, United States
Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler
- Conditions
- Interventions
- First Posted Date
- 2010-09-08
- Last Posted Date
- 2014-10-30
- Lead Sponsor
- Mannkind Corporation
- Target Recruit Count
- 39
- Registration Number
- NCT01196104
- Locations
- 🇺🇸
Billings Clinic Research Center, Billings, Montana, United States
🇺🇸Diabetes Research Center -Fletcher Allen Health Care, South Burlington, Vermont, United States
🇺🇸Coastal Clinical Research Inc, Mobile, Alabama, United States